researchers discovered a specific long non-coding RNA, which is named Meg3 and is crucial for controlling fibrosis formation in heart failure, in the past. Within the scope of the FIBREX project, the developed
promotes severe COVID-19 disease. PLoS One 2021 ;16(8) DOI: 10.1371/journal.pone.0255335 Koeken VACM. Controlling inflammation in the elderly with BCG vaccination. Sci Adv 2021;7(32) DOI: 10.1126/sciadv.abk1668 [...] Seyedebrahimi R, Skripuletz T, Moharrami Kasmaie F. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules 2021;11(9):1372 DOI: